Archive · 3 Sep 2025
Aayush Wellness Shares Hit Upper Circuit Following Labs Launch
Aayush Wellness, a small-cap stock, saw its shares rise for the second day after announcing its move into the healthcare diagnostics market.
The company launched Aayush Labs, an online platform for booking tests and receiving results.
India's diagnostics market is huge and expected to grow significantly.
Aayush Labs aims to make healthcare more accessible, affordable, and patient-focused.
The company is trying to grow by combining wellness, herbal products, and diagnostics, potentially leading to a more stable income.
The stock has shown strong gains recently, though it has also seen some ups and downs over the past year.
Aayush Wellness stock hit its 5% upper circuit for the second day.
The rally followed the launch of Aayush Labs, entering the ₹1.54 trillion diagnostics market.
Aayush Labs offers online test booking, home sample collection, and digital reports.
The diagnostics sector is projected to nearly double by 2030.
Aayush Labs aims to provide a wide range of tests and improve healthcare access.
- Who
- Aayush Wellness
- What
- Entered India's diagnostics market by launching Aayush Labs, causing stock to hit upper circuit.
- When
- Stock hit upper circuit on Wednesday, September 3
- Where
- India
- Why
- Due to entry into the diagnostics market and the launch of Aayush Labs.
- Company
- Aayush Wellness
- Stock Price (September 3)
- ₹87.72
- Upper Circuit
- 5%
- Market Entered
- India's Diagnostics Market
- Market Value (FY2024)
- ₹1.54 Trillion
- Projected Market Value (FY2030)
- ₹2.98 Trillion
- CAGR (2024-2030)
- 11.7%
- 52-week high
- ₹267.30 (July 2025)
- 52-week low
- ₹31.64 (September 2024)